DrugTimes, owned by BioSeed (Shanghai) Biotechnology Co., Ltd., is a new media-based service platform. It offers 5 services, which are new media, online and offline activities, business development and investment advisory, high end consulting, talent pool and high end recruiting. Currently ~100K professionals follow DrugTimes wechat official account, 30000 friends follow the LinkedIn account. The professionals are mainly from R&D, investment, CRO/CMO, regulatory and other relevant industries and sectors. DrugTimes is getting more and more popular among professionals in healthcare industries in China. The official website and the online classroom are being constructed, will be launched in January 2020.